Resonant Capital Advisors LLC Reduces Position in The Cigna Group (NYSE:CI)

Resonant Capital Advisors LLC lessened its holdings in shares of The Cigna Group (NYSE:CI) by 5.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 849 shares of the health services provider’s stock after selling 46 shares during the period. Resonant Capital Advisors LLC’s holdings in The Cigna Group were worth $234,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. ORG Wealth Partners LLC purchased a new stake in The Cigna Group during the fourth quarter worth $34,000. Ulland Investment Advisors LLC lifted its holdings in The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after buying an additional 100 shares during the period. Prospera Private Wealth LLC purchased a new stake in The Cigna Group during the third quarter worth $37,000. Harbor Capital Advisors Inc. purchased a new stake in The Cigna Group during the third quarter worth $45,000. Finally, Heck Capital Advisors LLC purchased a new stake in The Cigna Group during the fourth quarter worth $53,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

The Cigna Group Price Performance

Shares of CI opened at $292.56 on Tuesday. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The stock has a market cap of $81.38 billion, a PE ratio of 23.90, a price-to-earnings-growth ratio of 0.97 and a beta of 0.54. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The firm has a fifty day moving average price of $294.40 and a 200 day moving average price of $324.18.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the business earned $6.79 earnings per share. As a group, sell-side analysts anticipate that The Cigna Group will post 29.66 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a yield of 2.06%. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s dividend payout ratio (DPR) is currently 45.75%.

Wall Street Analyst Weigh In

CI has been the subject of a number of analyst reports. UBS Group lowered their target price on The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a report on Monday. Truist Financial reduced their price target on The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Piper Sandler reaffirmed an “overweight” rating and set a $348.00 price target (down from $394.00) on shares of The Cigna Group in a research report on Monday. Deutsche Bank Aktiengesellschaft reduced their price target on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research report on Monday, November 4th. Finally, StockNews.com downgraded The Cigna Group from a “buy” rating to a “hold” rating in a research report on Friday. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $378.00.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.